Plant polyisoprenoids and control of cholesterol level

Archivum Immunologiae et Therapiae Experimentalis

Volumn 62, Issue 1, 2014, Pages 31-39

  Pronin, Alexander V ^a   Danilov, Leonid L ^b   Narovlyansky, Alexander N ^a   Sanin, Alexander V ^a  

^a GAMALEYA RESEARCH INSTITUTE OF EPIDEMIOLOGY AND MICROBIOLOGY   (Russian Federation)

^b N D ZELINSKY INSTITUTE OF ORGANIC CHEMISTRY   (Russian Federation)

Author keywords

Sitosterol; Atherosclerosis; Cholesterol; Polyisoprenoids; Sitopren

Indexed keywords

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHOLESTEROL; DRUG-INDUCED LIVER INJURY; HUMANS; HYPERCHOLESTEROLEMIA; LIPOXYGENASE; PHYTOTHERAPY; PLANTS; SITOSTEROLS; TERPENES;

EID: 84895067594     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-013-0253-y     Document Type: Review

References (54)

1. Beltowski G, Wojcicka G, Jamroz-Wisniewska A (2009) Adverse effects of statins - mechanism and consequences. Curr Drug Saf 4:209-228
2. Bergamini E, Bizzarri R, Cavallini G et al (2004) Ageing and oxidative stress: a role of dolichol in the antioxidant machinery of cell membranes. J Alzheimers Dis 6:129-135
3. Binghorst M, Wortmann SB, Funke S et al (2012) Glycosylation defects underlying fetal alcohol spectrum disorder: a novel pathogenetic model. J Inherit Metab Dis 35:399-405
4. Blanc M, Hsieh WY, Robertson KA et al (2011) Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis. PLoS Biol 9:e1000598
5. Bonnans C, Levy BD (2007) Lipid mediators as agonists for the resolution of acute lung inflammation and injury. Am J Respir Cell Mol Biol 36:201-205
6. Buhaescu I, Izzedine H (2007) Mevalonate pathway: a review of clinical and therapeutical implications. Clin Biochem 40:575-584
7. Cantagrel V, Lefeber DJ (2011) From glycosylation disorders to dolichol biosynthesis defects: a new class of metabolic diseases. J Inherit Metab Dis 34:859-867
8. Cantagrel V, Lefeber DJ, Ng BG et al (2010) SRD5A3 is required for conversion of polyprenol to dolichol and is mutated in a congenital glycosylation disorder. Cell 142:203-217
9. Chojnacki T, Dallner E (1988) The biological role of dolichol. Biochem J 251:1-9
10. Clase AC, Lyman MG, del Rio T et al (2003) The pseudorabies virus Us2 protein, a virion tegument component, is prenylated in infected cells. J Virol 77:12285-12298
11. Danilov LL, Maltsev SD, Deyeva AV et al (1996) Phosprenyl: a novel drug with antiviral and immunomodulatory activity. Arch Immunol Ther Exp 44:395-400
12. Danilov LL, Deyeva AV, Mal'tsev SD et al (1999) Composition for prophylaxis and treatment of infections and for correction of pathological states of living organism. Patent RU 2129867
13. Danilov LL, Deeva AV, Kuritz T et al (2003) Therapeutic composition and methods. Patent US 6525035
14. Einav S, Glenn JS (2003) Prenylation inhibitors: a novel class of antiviral agents. J Antimicrob Chemother 52:883-886
15. Fernandez ML, Vega-Lopez S (2005) Efficacy and safety of sitosterol in the management of blood cholesterol levels. Cardiovasc Drug Rev 23:57-70
16. Goreta SS, Dabelic S, Dumic J (2012) Insight into complexity of congenital disorders of glycosylation. Biochem Med 22:156-170
17. Grundahl JEH, Guan Z, Rust S et al (2012) Life with too much polyprenol: polyprenol reductase deficiency. Mol Genet Metab 105:642-651
18. Gupta AK, Savapoulos CG, Ahuja G et al (2011) Role of phytosterols in lipid-lowering: current perspectives. QJM 104:301-308
19. Hartley MD, Imperiali B (2012) At the membrane frontier: a prospectus on the remarkable evolutionary conservation of polyprenols and polyprenyl phosphates. Arch Biochem Biophys 517:83-97
20. Ishimoto K, Tachibana K, Hanano I et al (2010) Sterol-regulatory-element- binding protein 2 and nuclear factor Y control human farnesyl diphosphate synthase expression and affect cell proliferation in hepatoblastoma cells. Biochem J 429:347-357
21. IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN) (1987) Prenol nomenclature recommendations. Eur J Biochem 167:181-184
22. Johnston TP (2004) The P-407-induced murine model of dose-controlled hyperlipidemia and atherosclerosis: a review of findings to date. J Cardiovasc Pharmacol 43:595-606
23. Jones MB, Rosenberg JN, Betenbaugh MJ et al (2009) Structure and synthesis of polyisoprenoids used in N-glycosylation across the three domains of life. Biochim Biophys Acta 1790:485-494
24. Kapadia SB, Chisari FV (2005) Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc Natl Acad Sci USA 102:2561-2566
25. Kozlov VV, Danilov LL (2012) Separation of polyprenyl phosphate oligomerhomologues by reversed-phase ion-pair high-performance liquid chromatography. Analyt Sci 28:1021-1023
26. Kranz C, Ungeblut C, Denecke J et al (2007) A defect in dolichol phosphate biosynthesis causes a new inherited disorder with death in early infancy. Am J Hum Gen 80:433-440
27. Kuritz T (2009) Methods and compositions for modulation of innate immunity. Patent US 0306017
28. Larkin A, Imperiali B (2011) The expanding horizons of asparagines-linked glycosylation. Biochemistry 50:4411-4426
29. Marangoni S, Poli A (2010) Phytosterols and cardiovascular health. Pharmacol Res 61:193-199
30. Marquart TJ, Allen RM, Ory DS et al (2010) miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci USA 107:12228-12232
31. Narovlyansky AN, Pronin AV, Sanin AV et al (2011) Biologically active additive and method for its production. Patent RU 2427284
32. Nebieridze DV, Chernova SI (2012) The investigation of efficiency and safety on administering combination of polyprenyl phosphate with beta-sitosterol in patients with disturbance of lipid metabolism (in Russian). Profilakticheskaya Medicina
33. Ozherelkov SV, Timofeyev AV, Novikova GP et al (2000) Protective action of novel antiviral preparation phosprenyl at experimental tick-borne encephalitis (in Russian). Vopr Virusol 45:33-37
34. Ozherelkov SV, Kupriyanov VV, Kalinina ES et al (2007) Interferonogenic activity of tick-borne encephalitis virus and polyprenyl-containing compounds in sensitive cell cultures (in Russian). In: Interferon-50 let [50th Anniversary of the Interferon], Proceedings of the Conference, 19-20 November, Moscow, pp 184-191
35. Pronin AV, Ozherelkov SV, Deyeva AV et al (2012) Polyprenyl phosphates as adjuvants polarizing immune response in the direction of Th1 (in Russian). Infektsiya Immunitet 3:645-650
36. Rauthan M, Pilon M (2011) The mevalonate pathway in C. elegans. Lipids Health Dis 10:243-254
37. Roschin VI, Soultanov VS (2003) Preparation for stimulation of natural regeneration of liver. Patent RU 2252026
38. Rozner S, Garti N (2006) The activity and absorption relationship of cholesterol and phytosterols. Colloids Surf A 282-283:435-456
39. Sanin AV, Ganshina IV, Sud'ina GF et al (2011) Phosphorylated polyprenols - a novel class of compounds with anti-inflammatory and broncholytic activity (in Russian). Infektsiya Immunitet 1:355-360
40. Sasaki J, Otonari T, Sawayama Y et al (2011) Double-dose pravastatin versus add-on ezetimibe with low-dose pravastatin - effects on LDL cholesterol, cholesterol absorption, and cholesterol synthesis in Japanese patients with hypercholesterolemia (PEAS study). J Atheroscler Thromb 18:1-9
41. Sato R (2010) Sterol metabolism and SREBP activation. Arch Biochem Biophys 501:177-181
42. Schenk B, Fernandez F, Waechter CJ (2001) The ins(ide) and outs(ide) of dolichyl phosphate biosynthesis and recycling in the endoplasmic reticulum. Glycobiology 11:61R-70R
43. Singh G, Gupta P, Rawat P (2007) Antidyslipidemic activity of polyprenol from Coccinia grandis in high-fat diet-fed hamster model. Phytomedicine 14:792-798
44. Skorupinska-Tudek K, Wojcik J, Swiezewska E (2008) Polyisoprenoid alcohols - recent results of structural studies. Chem Rec 8:33-45
45. Soultanov VS, Agishev VG, Monahova IA et al (2010) Ropren improves liver and pancreatic functions in patients with chronic alcoholism. Gastroenterologia Sankt-Peterburga 4:12-17
46. Surmacz L, Swiezewska E (2011) Polyisoprenoids - secondary metabolites or physiologically important superlipids? Biochem Biophys Res Comm 407:627-632
47. Swiezewska E, Danikiewicz W (2005) Polyisoprenoids: structure, biosynthesis and function. Progr Lipid Res 44:235-258
48. Tamilselvan N, Thirumalai T, Elumalai EK et al (2011) Pharmacognosy of Coccinia grandis: a review. Asian Pac J Trop Biomed 211:S299-S302
49. Tremblay AJ, Lamarche B, Lemelin V et al (2011) Atorvastatin increases intestinal expression of NPLC1L1 in hyperlipidemic men. J Lipid Res 52:558-565
50. Vasil'ev AN, Ozherelkov SV, Kozlov VV et al (2008) Antiviral and immunomodulatory activity of polyprenyl phosphates at viral infections (in Russian). Antibiotiki Khimioterapiya 53:3-8
51. Wang X, Mansourian AR, Quinn PJ (2008) The effect of dolichol on structure and phase behavior of phospholipid model membranes. Mol Membr Biol 25:547-556
52. Yamatsu I, Suzuki T, Abe S et al (1986) Therapeutic and preventive agent containing dolichol. Patent US 4613593
53. 4-induced hepatotoxicity in rats. Fitoterapia 82:834-840
54. 4-induced liver fibrosis in rats. J Ethnopharmacol 142:151-160